Alexion Pharmaceuticals Inc. (ALXN) Announces The Appointments Of David R. Brennan, M. Michele Burns And Christopher J. Coughlin To Its Board Of Directors
7/16/2014 9:03:36 AM
CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced the appointments of David R. Brennan, M. Michele Burns and Christopher J. Coughlin to the Company’s Board of Directors, effective immediately. With the appointments announced today, 10 of Alexion's 11 directors are independent.
“David, Michele and Chris bring significant commercial, financial, risk management and operational expertise to the Board, and, following on the May 2014 Board appointment of Jack Mollen, further enhance Alexion’s corporate governance. Their global operational expertise and experience serving on the Boards of other multinational organizations will be valuable to our growing business and we are pleased to welcome them to the Alexion Board of Directors,” said Max Link, Ph.D., Chairman of Alexion’s Board of Directors.
Help employers find you! Check out all the jobs and post your resume.
comments powered by